Swisher Financial Concepts Inc. Sells 575 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Swisher Financial Concepts Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 42.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 768 shares of the healthcare conglomerate’s stock after selling 575 shares during the quarter. Swisher Financial Concepts Inc.’s holdings in UnitedHealth Group were worth $388,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Western Pacific Wealth Management LP lifted its position in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares during the last quarter. MCF Advisors LLC grew its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after acquiring an additional 20 shares during the last quarter. Axiom Financial Strategies LLC raised its stake in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after purchasing an additional 20 shares during the last quarter. Richwood Investment Advisors LLC grew its position in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after purchasing an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC raised its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $524.56 on Tuesday. The firm has a market cap of $479.82 billion, a price-to-earnings ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a 50-day moving average price of $508.87 and a 200 day moving average price of $541.48.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.83 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

Several research firms have commented on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.